Form 4: HealthStream Director Deborah Taylor Tate Reports Stock Transactions

Director Deborah Taylor Tate reports the vesting of restricted share units and acquisition of common stock in HealthStream Inc.

Summary

• On March 25, 2024, Deborah Taylor Tate, a director of HealthStream Inc. (HSTM), reported transactions involving restricted share units (RSUs) and common stock.
• Ms. Tate acquired 2,092 shares of common stock upon the vesting of RSUs.
• She also reported holding 22,601 shares of common stock directly.
• The RSUs vest annually over a three-year period, contingent upon continued service.
• Specifically, 944 RSUs vested from a grant that began vesting on March 17, 2022, and 1,148 RSUs vested from a grant that began vesting on March 23, 2023.
• Following these transactions, Ms. Tate directly holds 1,149 restricted share units.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document simply reports transactions related to previously granted compensation.

Positives

• The vesting of RSUs indicates that performance metrics or service requirements have been met.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. These transactions provide transparency into the actions of company insiders.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect the standard compensation practices for company directors.

Key Dates